[
  {
    "title": "Is Amgen Stock a Buy?",
    "link": "https://finance.yahoo.com/news/amgen-stock-buy-084500670.html"
  },
  {
    "title": "2 Dow Jones Stocks with Promising Prospects and 1 to Avoid",
    "link": "https://finance.yahoo.com/news/2-dow-jones-stocks-promising-043358884.html"
  },
  {
    "title": "Possible Bearish Signals With Amgen Insiders Disposing Stock",
    "link": "https://finance.yahoo.com/news/possible-bearish-signals-amgen-insiders-120028584.html"
  },
  {
    "title": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
    "link": "https://finance.yahoo.com/news/investors-heavily-search-amgen-inc-130009881.html"
  },
  {
    "title": "With 81% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns",
    "link": "https://finance.yahoo.com/news/81-institutional-ownership-amgen-inc-140011063.html"
  },
  {
    "title": "The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now",
    "link": "https://finance.yahoo.com/news/smartest-high-yielding-dividend-stocks-111500177.html"
  },
  {
    "title": "U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result",
    "link": "https://finance.yahoo.com/news/u-pharmaceutical-imports-might-soon-081100447.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Eli Lilly, GE Aerospace and Amgen",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-eli-124200981.html"
  },
  {
    "title": "Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen",
    "link": "https://finance.yahoo.com/news/top-analyst-reports-eli-lilly-203400904.html"
  },
  {
    "title": "Better Weight Loss Stock: Amgen or Viking Therapeutics?",
    "link": "https://finance.yahoo.com/news/better-weight-loss-stock-amgen-150500162.html"
  },
  {
    "title": "Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying",
    "link": "https://finance.yahoo.com/m/0dc4812d-09f8-322e-b873-8f766a7f20f3/sanofi-inks-a-470-million.html"
  },
  {
    "title": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
    "link": "https://finance.yahoo.com/news/value-investor-1-stock-could-134009596.html"
  },
  {
    "title": "AMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes Linger",
    "link": "https://finance.yahoo.com/news/amgn-down-10-3-months-125000164.html"
  },
  {
    "title": "Viridian Therapeutics’ veligrotug shows durability in Phase III TED trial",
    "link": "https://finance.yahoo.com/news/viridian-therapeutics-veligrotug-shows-durability-110302199.html"
  },
  {
    "title": "Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?",
    "link": "https://finance.yahoo.com/news/amgen-vs-bristol-myers-biotech-172900072.html"
  },
  {
    "title": "2 Safe-and-Steady Stocks Worth Your Attention and 1 to Avoid",
    "link": "https://finance.yahoo.com/news/2-safe-steady-stocks-worth-043927561.html"
  },
  {
    "title": "AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE",
    "link": "https://finance.yahoo.com/news/amgen-present-2025-rbc-capital-200100775.html"
  },
  {
    "title": "Amgen (NasdaqGS:AMGN) Faces US$407 Million Verdict Over Antitrust Violations",
    "link": "https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-faces-us-173029146.html"
  },
  {
    "title": "Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price",
    "link": "https://finance.yahoo.com/m/bbb82497-a426-3bce-81c3-efa6923f220d/novo-nordisk-sheds-3-after.html"
  },
  {
    "title": "Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock",
    "link": "https://finance.yahoo.com/news/know-beyond-why-amgen-inc-130009580.html"
  },
  {
    "title": "Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff",
    "link": "https://finance.yahoo.com/news/regeneron-defeats-amgen-pcsk9-case-103600057.html"
  },
  {
    "title": "AMGN Q1 Earnings Call: Product Pipeline and Margin Expansion Drive Outperformance",
    "link": "https://finance.yahoo.com/news/amgn-q1-earnings-call-product-204203128.html"
  },
  {
    "title": "3 Healthcare Stocks to Research Further",
    "link": "https://finance.yahoo.com/news/3-healthcare-stocks-research-further-043318387.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-best-pharma-210116767.html"
  },
  {
    "title": "Trump's drug price order is part request, part threat: Analyst",
    "link": "https://finance.yahoo.com/video/trumps-drug-price-order-part-232000676.html"
  },
  {
    "title": "S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'",
    "link": "https://finance.yahoo.com/m/8bbeb00f-58ab-3bfb-8fe9-492a82597341/s-p-dow-pharma-stocks.html"
  },
  {
    "title": "How Trump could go about executing order to slash drug prices",
    "link": "https://finance.yahoo.com/video/trump-could-executing-order-slash-195046744.html"
  },
  {
    "title": "Interested In Amgen's (NASDAQ:AMGN) Upcoming US$2.38 Dividend? You Have Four Days Left",
    "link": "https://finance.yahoo.com/news/interested-amgens-nasdaq-amgn-upcoming-120546418.html"
  },
  {
    "title": "AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE",
    "link": "https://finance.yahoo.com/news/amgen-present-bank-america-merrill-200100286.html"
  },
  {
    "title": "2 Unstoppable Dividend Stocks to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/2-unstoppable-dividend-stocks-buy-135300273.html"
  },
  {
    "title": "Amgen Inc. (AMGN): A Bull Case Theory",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-bull-case-185234081.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) the Best Dow Stock?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-best-dow-181838465.html"
  },
  {
    "title": "Here's Why Amgen (AMGN) is a Strong Growth Stock",
    "link": "https://finance.yahoo.com/news/heres-why-amgen-amgn-strong-134507732.html"
  },
  {
    "title": "Here's Why Amgen (AMGN) is a Strong Value Stock",
    "link": "https://finance.yahoo.com/news/heres-why-amgen-amgn-strong-134008763.html"
  },
  {
    "title": "Is Trending Stock Amgen Inc. (AMGN) a Buy Now?",
    "link": "https://finance.yahoo.com/news/trending-stock-amgen-inc-amgn-130009746.html"
  },
  {
    "title": "AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth",
    "link": "https://finance.yahoo.com/news/amgns-key-drugs-repatha-evenity-120100859.html"
  },
  {
    "title": "Amgen (NasdaqGS:AMGN) Reports Strong Q1 Earnings With Revenue Increase To US$8 Billion",
    "link": "https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-reports-strong-172736155.html"
  },
  {
    "title": "Amgen’s Stelara biosimilar gets off to fast start",
    "link": "https://finance.yahoo.com/news/amgen-stelara-biosimilar-gets-off-121600129.html"
  },
  {
    "title": "Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth",
    "link": "https://finance.yahoo.com/news/amgens-q1-earnings-beat-estimates-115000091.html"
  },
  {
    "title": "Amgen Inc (AMGN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Pricing Challenges",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-q1-2025-071543087.html"
  },
  {
    "title": "Compared to Estimates, Amgen (AMGN) Q1 Earnings: A Look at Key Metrics",
    "link": "https://finance.yahoo.com/news/compared-estimates-amgen-amgn-q1-213006247.html"
  },
  {
    "title": "Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates",
    "link": "https://finance.yahoo.com/news/amgen-amgn-tops-q1-earnings-211005131.html"
  },
  {
    "title": "Amgen beats Q1 expectations, issues solid full-year outlook",
    "link": "https://finance.yahoo.com/news/amgen-beats-q1-expectations-issues-204117596.html"
  },
  {
    "title": "Amgen posts profit, says tax policy more effective than tariffs",
    "link": "https://finance.yahoo.com/news/amgen-quarterly-profit-tops-wall-202257656.html"
  },
  {
    "title": "Amgen beats Q1 earnings, revenue estimates. Stock flat.",
    "link": "https://finance.yahoo.com/video/amgen-beats-q1-earnings-revenue-202004812.html"
  },
  {
    "title": "Amgen: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/amgen-q1-earnings-snapshot-200833144.html"
  },
  {
    "title": "Amgen’s (NASDAQ:AMGN) Q1: Beats On Revenue",
    "link": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-q1-beats-200735267.html"
  },
  {
    "title": "AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS",
    "link": "https://finance.yahoo.com/news/amgen-reports-first-quarter-2025-200100246.html"
  },
  {
    "title": "Beat the Nasdaq With This Cash-Gushing Dividend Stock",
    "link": "https://finance.yahoo.com/news/beat-nasdaq-cash-gushing-dividend-123000603.html"
  },
  {
    "title": "Amazon and Apple earnings coverage, Eli Lilly: What to Watch",
    "link": "https://finance.yahoo.com/video/amazon-apple-earnings-coverage-eli-230052060.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) the Best Dow Stock for the Next 12 Months?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-best-dow-183539284.html"
  },
  {
    "title": "Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?",
    "link": "https://finance.yahoo.com/news/amgen-amgn-beat-estimates-again-161002228.html"
  },
  {
    "title": "Amgen (AMGN) Reports Earnings Tomorrow: What To Expect",
    "link": "https://finance.yahoo.com/news/amgen-amgn-reports-earnings-tomorrow-071434156.html"
  },
  {
    "title": "Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know",
    "link": "https://finance.yahoo.com/news/caribou-biosciences-inc-crbu-report-140124253.html"
  },
  {
    "title": "Can Amgen Keep the Beat Streak Alive This Earnings Season?",
    "link": "https://finance.yahoo.com/news/amgen-keep-beat-streak-alive-104200796.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-103200684.html"
  },
  {
    "title": "AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS",
    "link": "https://finance.yahoo.com/news/amgen-announces-webcast-2025-first-200100621.html"
  },
  {
    "title": "Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?",
    "link": "https://finance.yahoo.com/news/5-big-drug-stocks-surpass-160800036.html"
  },
  {
    "title": "Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs",
    "link": "https://finance.yahoo.com/news/eli-lilly-pfizer-risk-billions-152037442.html"
  },
  {
    "title": "Amgen (AMGN) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
    "link": "https://finance.yahoo.com/news/amgen-amgn-q1-earnings-horizon-131553135.html"
  },
  {
    "title": "Amgen to invest $900m in Ohio manufacturing facility",
    "link": "https://finance.yahoo.com/news/amgen-invest-900m-ohio-manufacturing-103712408.html"
  },
  {
    "title": "4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off",
    "link": "https://finance.yahoo.com/news/4-surefire-dividend-stocks-buy-220500399.html"
  },
  {
    "title": "Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment",
    "link": "https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-expands-ohio-171619127.html"
  },
  {
    "title": "Pharma reshoring: Amgen invests $900M in Ohio biotech facility",
    "link": "https://finance.yahoo.com/video/pharma-reshoring-amgen-invests-900m-210627072.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Advance in Afternoon Trading",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-advance-175804950.html"
  },
  {
    "title": "Amgen to expand Ohio biotech manufacturing plant",
    "link": "https://finance.yahoo.com/news/amgen-expand-ohio-biotech-manufacturing-171225684.html"
  },
  {
    "title": "AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO",
    "link": "https://finance.yahoo.com/news/amgen-announces-900-million-manufacturing-164700052.html"
  },
  {
    "title": "Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca",
    "link": "https://finance.yahoo.com/news/apple-microsoft-shell-hsbc-lloyds-astrazeneca-stocks-to-watch-050019911.html"
  },
  {
    "title": "Amgen (AMGN) Earnings Expected to Grow: Should You Buy?",
    "link": "https://finance.yahoo.com/news/amgen-amgn-earnings-expected-grow-140135629.html"
  },
  {
    "title": "1 Value Stock to Research Further and 2 to Ignore",
    "link": "https://finance.yahoo.com/news/1-value-stock-research-further-130154626.html"
  },
  {
    "title": "3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold",
    "link": "https://finance.yahoo.com/news/3-relatively-safe-healthcare-growth-135300768.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) a Cheap NASDAQ Stock to Buy According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-cheap-nasdaq-134934209.html"
  },
  {
    "title": "Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy",
    "link": "https://finance.yahoo.com/news/cantor-initiates-coverage-u-large-134801368.html"
  },
  {
    "title": "Amgen (AMGN) Stock Moves -1.3%: What You Should Know",
    "link": "https://finance.yahoo.com/news/amgen-amgn-stock-moves-1-215033952.html"
  },
  {
    "title": "Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?",
    "link": "https://finance.yahoo.com/news/most-watched-stock-amgen-inc-130010450.html"
  },
  {
    "title": "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know",
    "link": "https://finance.yahoo.com/news/amgen-amgn-stock-sinks-market-220013239.html"
  },
  {
    "title": "Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-among-innovative-134528561.html"
  },
  {
    "title": "2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/2-dividend-stocks-defying-tariff-125600123.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Rise Monday Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-180801475.html"
  },
  {
    "title": "Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit",
    "link": "https://finance.yahoo.com/news/sandoz-challenges-amgen-enbrel-patents-105927320.html"
  },
  {
    "title": "Amgen’s Phase III trial of Imdelltra meets primary endpoint for SCLC",
    "link": "https://finance.yahoo.com/news/amgen-phase-iii-trial-imdelltra-092716178.html"
  },
  {
    "title": "Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug",
    "link": "https://finance.yahoo.com/news/switzerlands-sandoz-files-antitrust-lawsuit-051213344.html"
  },
  {
    "title": "Amgen (AMGN) Gains But Lags Market: What You Should Know",
    "link": "https://finance.yahoo.com/news/amgen-amgn-gains-lags-market-220014482.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Rise in Late Afternoon Trading",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-195921592.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Gain in Afternoon Trading",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-gain-181242235.html"
  },
  {
    "title": "Amgen (NasdaqGS:AMGN) Clinical Trial Success In SCLC Treatment With IMDELLTRA",
    "link": "https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-clinical-trial-171650144.html"
  },
  {
    "title": "IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER",
    "link": "https://finance.yahoo.com/news/imdelltra-demonstrated-superior-overall-survival-130000200.html"
  },
  {
    "title": "Pharma’s US manufacturing moment: Where companies are making the biggest moves",
    "link": "https://finance.yahoo.com/news/pharma-manufacturing-moment-where-companies-071322162.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pacira-090000796.html"
  },
  {
    "title": "Amgen Is Getting Into the Obesity Drug Business. Buy the Stock Before It Becomes the  Next Winner.",
    "link": "https://finance.yahoo.com/m/c0e55695-ba45-3f93-ba74-ac1d464acb6d/amgen-is-getting-into-the.html"
  },
  {
    "title": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-attracting-investor-130008477.html"
  },
  {
    "title": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "link": "https://finance.yahoo.com/news/3-dividend-stocks-buy-hold-104400951.html"
  },
  {
    "title": "2 Dividend Stocks to Buy Hand Over Fist in April",
    "link": "https://finance.yahoo.com/news/2-dividend-stocks-buy-hand-123000661.html"
  },
  {
    "title": "Amgen (NasdaqGS:AMGN) Gains FDA Approval For UPLIZNA In Treating IgG4-Related Disease",
    "link": "https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-gains-fda-173424312.html"
  },
  {
    "title": "AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication",
    "link": "https://finance.yahoo.com/news/amgns-uplizna-gets-fda-nod-171000251.html"
  },
  {
    "title": "Amgen (AMGN) Rises As Market Takes a Dip: Key Facts",
    "link": "https://finance.yahoo.com/news/amgen-amgn-rises-market-takes-215009107.html"
  },
  {
    "title": "Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday",
    "link": "https://finance.yahoo.com/news/why-clutch-pharmaceutical-biotech-stocks-205048111.html"
  },
  {
    "title": "UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE",
    "link": "https://finance.yahoo.com/news/uplizna-inebilizumab-cdon-now-first-193500981.html"
  },
  {
    "title": "US FDA approves Amgen's Uplizna as first treatment for rare immune disorder",
    "link": "https://finance.yahoo.com/news/us-fda-approves-amgens-uplizna-184948483.html"
  },
  {
    "title": "Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks",
    "link": "https://finance.yahoo.com/news/q4-earnings-outperformers-amgen-nasdaq-090834226.html"
  },
  {
    "title": "Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now",
    "link": "https://finance.yahoo.com/news/got-5-000-3-nasdaq-090500706.html"
  },
  {
    "title": "GILD or AMGN: Which Is the Better Value Stock Right Now?",
    "link": "https://finance.yahoo.com/news/gild-amgn-better-value-stock-154007035.html"
  },
  {
    "title": "Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1",
    "link": "https://finance.yahoo.com/m/20c391ee-2785-3fce-a032-6cdb4b7efc58/nvidia-other-techs-hurt-dow.html"
  },
  {
    "title": "These biotech names aren't facing 'huge concern' from tariffs",
    "link": "https://finance.yahoo.com/video/biotech-names-arent-facing-huge-113025462.html"
  },
  {
    "title": "Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing",
    "link": "https://finance.yahoo.com/news/amgen-amgn-surpasses-market-returns-220015558.html"
  },
  {
    "title": "RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar",
    "link": "https://finance.yahoo.com/news/rdy-bio-thera-ink-deal-133000551.html"
  },
  {
    "title": "2 Surefire Dividend Stocks That Could Pay You for Life",
    "link": "https://finance.yahoo.com/news/2-surefire-dividend-stocks-could-141500794.html"
  },
  {
    "title": "2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down",
    "link": "https://finance.yahoo.com/news/2-large-cap-stocks-solid-130117143.html"
  },
  {
    "title": "Which Dow Jones Stock Is Cheaper, Amgen or Merck?",
    "link": "https://finance.yahoo.com/news/dow-jones-stock-cheaper-amgen-123000694.html"
  },
  {
    "title": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
    "link": "https://finance.yahoo.com/m/a0a5b586-6548-32ba-a471-4b92d7cd09e4/trump-weighs-tariffs-on.html"
  },
  {
    "title": "VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug",
    "link": "https://finance.yahoo.com/news/vktx-finishes-enrolment-mid-stage-123100379.html"
  },
  {
    "title": "How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology",
    "link": "https://finance.yahoo.com/news/az-amgen-tezspire-respiratory-data-072744649.html"
  },
  {
    "title": "Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note",
    "link": "https://finance.yahoo.com/news/amgen-amgn-stock-drops-despite-215014605.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) The Best Healthcare Dividend Stock to Invest in?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-best-healthcare-174716666.html"
  },
  {
    "title": "Why Amgen (AMGN) is a Top Value Stock for the Long-Term",
    "link": "https://finance.yahoo.com/news/why-amgen-amgn-top-value-141006158.html"
  },
  {
    "title": "3 of Goldman Sachs' best investing tips for currently volatile markets",
    "link": "https://finance.yahoo.com/news/3-of-goldman-sachs-best-investing-tips-for-currently-volatile-markets-133052214.html"
  },
  {
    "title": "FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review",
    "link": "https://finance.yahoo.com/news/fda-accepts-rdy-alvos-prolia-151300159.html"
  },
  {
    "title": "Why the Market Dipped But Amgen (AMGN) Gained Today",
    "link": "https://finance.yahoo.com/news/why-market-dipped-amgen-amgn-215016843.html"
  },
  {
    "title": "Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?",
    "link": "https://finance.yahoo.com/news/amgen-rises-almost-22-ytd-154900941.html"
  },
  {
    "title": "Prediction: These 2 Stocks Will Outperform the Market Through 2030",
    "link": "https://finance.yahoo.com/news/prediction-2-stocks-outperform-market-135300447.html"
  },
  {
    "title": "Amgen Inc. (AMGN): Among the Best Biotech Stocks to Buy According to Billionaires",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-best-biotech-233929271.html"
  },
  {
    "title": "Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider",
    "link": "https://finance.yahoo.com/news/amgen-amgn-exceeds-market-returns-220014972.html"
  },
  {
    "title": "AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study",
    "link": "https://finance.yahoo.com/news/amgn-posts-upbeat-data-uplizna-160500075.html"
  },
  {
    "title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-trending-stock-130008808.html"
  },
  {
    "title": "Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer",
    "link": "https://finance.yahoo.com/news/amgen-data-muddies-outlook-cartesian-161514365.html"
  },
  {
    "title": "Amgen’s gMG therapy cuts disease symptoms at one-year mark",
    "link": "https://finance.yahoo.com/news/amgen-gmg-therapy-cuts-disease-173106978.html"
  },
  {
    "title": "Amgen (NasdaqGS:AMGN) Announces Promising MINT Trial Data For UPLIZNA In Generalized Myasthenia Gravis",
    "link": "https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-announces-promising-172119931.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-best-pharma-160919207.html"
  },
  {
    "title": "Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year",
    "link": "https://finance.yahoo.com/news/amgens-uplizna-shows-improved-symptoms-153626401.html"
  },
  {
    "title": "Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?",
    "link": "https://finance.yahoo.com/news/exelixis-exel-13-4-since-153029170.html"
  },
  {
    "title": "Amgen Says Phase 3 Data Support Uplizna's Efficacy in Generalized Myasthenia Gravis",
    "link": "https://finance.yahoo.com/news/amgen-says-phase-3-data-135823238.html"
  },
  {
    "title": "Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick",
    "link": "https://finance.yahoo.com/news/momentum-investor-1-stock-could-135007163.html"
  },
  {
    "title": "UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS",
    "link": "https://finance.yahoo.com/news/uplizna-inebilizumab-cdon-significantly-improves-130000205.html"
  },
  {
    "title": "Amgen Inc. (AMGN): Among Dobermans of the Dow to Buy",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-among-dobermans-140443999.html"
  },
  {
    "title": "HALO vs. AMGN: Which Stock Is the Better Value Option?",
    "link": "https://finance.yahoo.com/news/halo-vs-amgn-stock-better-154008458.html"
  },
  {
    "title": "Stock market sell-off: Why these stocks are in the green amid the pain",
    "link": "https://finance.yahoo.com/news/stock-market-sell-off-why-these-stocks-are-in-the-green-amid-the-pain-181712451.html"
  },
  {
    "title": "AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies",
    "link": "https://finance.yahoo.com/news/amgns-eczema-drug-meets-goal-132700356.html"
  },
  {
    "title": "Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints",
    "link": "https://finance.yahoo.com/news/amgen-kyowa-kirin-rocatinlimab-trial-113032134.html"
  },
  {
    "title": "Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus",
    "link": "https://finance.yahoo.com/news/zacks-approach-beat-markets-niocorp-103500611.html"
  },
  {
    "title": "3 Magnificent Growth Stocks to Buy in March",
    "link": "https://finance.yahoo.com/news/3-magnificent-growth-stocks-buy-154100845.html"
  },
  {
    "title": "AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS",
    "link": "https://finance.yahoo.com/news/amgen-kyowa-kirin-top-line-110000762.html"
  },
  {
    "title": "Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?",
    "link": "https://finance.yahoo.com/news/qiagen-qgen-down-6-since-163102605.html"
  },
  {
    "title": "2 Dividend Stocks to Buy for a Lifetime of Passive Income",
    "link": "https://finance.yahoo.com/news/2-dividend-stocks-buy-lifetime-100300458.html"
  },
  {
    "title": "Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup",
    "link": "https://finance.yahoo.com/news/wegovys-price-cut-amgens-ozempic-100000909.html"
  },
  {
    "title": "Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue?",
    "link": "https://finance.yahoo.com/news/amgen-amgn-2-9-since-163100670.html"
  },
  {
    "title": "2 Reasons to Watch AMGN and 1 to Stay Cautious",
    "link": "https://finance.yahoo.com/news/2-reasons-watch-amgn-1-090045846.html"
  },
  {
    "title": "Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-among-best-204915409.html"
  },
  {
    "title": "Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out",
    "link": "https://finance.yahoo.com/m/32d0d7c8-0bd1-33f4-8155-c5cc92624c9b/johnson-johnson-and-4-other.html"
  },
  {
    "title": "Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025",
    "link": "https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-declares-us-171507864.html"
  },
  {
    "title": "With patent losses on the horizon, Amgen refocuses its business strategy",
    "link": "https://finance.yahoo.com/news/patent-losses-horizon-amgen-refocuses-080000019.html"
  },
  {
    "title": "AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND",
    "link": "https://finance.yahoo.com/news/amgen-announces-2025-second-quarter-210100401.html"
  },
  {
    "title": "Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP",
    "link": "https://finance.yahoo.com/news/amgen-astrazeneca-report-results-phase-124450000.html"
  },
  {
    "title": "POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS",
    "link": "https://finance.yahoo.com/news/positive-results-tezspire-tezepelumab-ekko-223000167.html"
  },
  {
    "title": "Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-invests-200m-223744169.html"
  },
  {
    "title": "AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE",
    "link": "https://finance.yahoo.com/news/amgen-present-45th-annual-td-210100755.html"
  },
  {
    "title": "Why Amgen Inc. (AMGN) is the Best Vaccine Stock to Buy According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/why-amgen-inc-amgn-best-173124937.html"
  },
  {
    "title": "This Could Be the Best GLP-1 Stock to Buy in 2025",
    "link": "https://finance.yahoo.com/news/could-best-glp-1-stock-134500393.html"
  },
  {
    "title": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "link": "https://finance.yahoo.com/m/c6f9c271-5c7a-38f9-9f1a-5c020646702d/drug-stocks-are-the-new-safe.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) the Best Retirement Stock to Buy According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-best-retirement-093531266.html"
  },
  {
    "title": "These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?",
    "link": "https://finance.yahoo.com/news/3-dow-jones-stocks-crushing-095300685.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Advance Late Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-advance-205109167.html"
  },
  {
    "title": "Is Amgen Inc. (AMGN) One of the Best Performing Dow Stocks So Far in 2025?",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-one-best-150020159.html"
  },
  {
    "title": "5 Stocks in the Dow ETF That Survived the Worst Week Since October",
    "link": "https://finance.yahoo.com/news/5-stocks-dow-etf-survived-143000372.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-abbvie-091700389.html"
  },
  {
    "title": "Drugmaker Amgen to invest $200 million in India site, CEO says",
    "link": "https://finance.yahoo.com/news/amgen-plans-200-million-investment-062826110.html"
  },
  {
    "title": "Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-among-cheap-041246727.html"
  },
  {
    "title": "4 Seniors & Aging Demographics Stocks to Watch Right Now",
    "link": "https://finance.yahoo.com/news/4-seniors-aging-demographics-stocks-160600452.html"
  },
  {
    "title": "There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings",
    "link": "https://finance.yahoo.com/news/may-bright-spots-amgens-nasdaq-105551106.html"
  },
  {
    "title": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
    "link": "https://finance.yahoo.com/news/why-1-momentum-stock-could-145011870.html"
  },
  {
    "title": "Amgen Full Year 2024 Earnings: EPS Misses Expectations",
    "link": "https://finance.yahoo.com/news/amgen-full-2024-earnings-eps-101131557.html"
  },
  {
    "title": "Amgen Inc. (AMGN): Among the Best Drug Stocks to Buy Now",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-among-best-075009864.html"
  },
  {
    "title": "AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT",
    "link": "https://finance.yahoo.com/news/amgen-present-citis-2025-virtual-210100855.html"
  },
  {
    "title": "Moderna's Q4 loss: Can the pharma giant get to profitability?",
    "link": "https://finance.yahoo.com/video/modernas-q4-loss-pharma-giant-145124026.html"
  },
  {
    "title": "Why This 1 Value Stock Could Be a Great Addition to Your Portfolio",
    "link": "https://finance.yahoo.com/news/why-1-value-stock-could-144008556.html"
  },
  {
    "title": "Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move",
    "link": "https://finance.yahoo.com/news/investing-1-000-3-beaten-111500080.html"
  },
  {
    "title": "3 Fabulous Dividend Stocks to Buy in February",
    "link": "https://finance.yahoo.com/news/3-fabulous-dividend-stocks-buy-193000688.html"
  },
  {
    "title": "Don't Race Out To Buy Amgen Inc. (NASDAQ:AMGN) Just Because It's Going Ex-Dividend",
    "link": "https://finance.yahoo.com/news/dont-race-buy-amgen-inc-130822945.html"
  },
  {
    "title": "Amgen Inc. (AMGN): ‘Absurd That This Stock Sells for 14x Earnings’ – Jim Cramer on Blockbuster Drugs",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-absurd-stock-220135306.html"
  },
  {
    "title": "AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE",
    "link": "https://finance.yahoo.com/news/amgen-present-35th-annual-oppenheimer-210100182.html"
  },
  {
    "title": "Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.38",
    "link": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-announced-increasing-124249103.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-102300630.html"
  },
  {
    "title": "Company News for Feb 6, 2025",
    "link": "https://finance.yahoo.com/news/company-news-feb-6-2025-092300775.html"
  },
  {
    "title": "Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs",
    "link": "https://finance.yahoo.com/m/eff9009e-5301-39f2-b3f4-8c75fbd52c97/amgen-shrugs-off-a-surprise.html"
  },
  {
    "title": "Why Amgen (AMGN) Stock Is Trading Up Today",
    "link": "https://finance.yahoo.com/news/why-amgen-amgn-stock-trading-180917592.html"
  },
  {
    "title": "Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval",
    "link": "https://finance.yahoo.com/news/biotech-stock-roundup-regn-q4-164700984.html"
  },
  {
    "title": "AMGN's Q4 Earnings Beat, Obesity Candidate Under FDA Clinical Hold",
    "link": "https://finance.yahoo.com/news/amgns-q4-earnings-beat-obesity-155500258.html"
  },
  {
    "title": "Amgen obesity drug on hold; Regeneron sets first dividend",
    "link": "https://finance.yahoo.com/news/amgen-obesity-drug-hold-regeneron-112800700.html"
  },
  {
    "title": "Amgen stock slips on annual outlook; Q4 results top estimates",
    "link": "https://finance.yahoo.com/news/amgen-stock-falls-profit-outlook-213423274.html"
  },
  {
    "title": "Amgen Inc (AMGN) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions",
    "link": "https://finance.yahoo.com/news/amgen-inc-amgn-q4-2024-071255052.html"
  },
  {
    "title": "Amgen (AMGN) Q4 2024 Earnings Call Transcript",
    "link": "https://finance.yahoo.com/news/amgen-amgn-q4-2024-earnings-051513570.html"
  },
  {
    "title": "Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics",
    "link": "https://finance.yahoo.com/news/compared-estimates-amgen-amgn-q4-003005421.html"
  },
  {
    "title": "Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug",
    "link": "https://finance.yahoo.com/news/amgen-discloses-fda-paused-study-223543602.html"
  },
  {
    "title": "Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates",
    "link": "https://finance.yahoo.com/news/amgen-amgn-q4-earnings-revenues-221006749.html"
  },
  {
    "title": "Amgen, Enphase Energy, Mondelez: After-Hours Earnings",
    "link": "https://finance.yahoo.com/video/amgen-enphase-energy-mondelez-hours-215735996.html"
  },
  {
    "title": "Amgen’s (NASDAQ:AMGN) Q4 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations",
    "link": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-q4-sales-211835738.html"
  },
  {
    "title": "Amgen: Q4 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/amgen-q4-earnings-snapshot-210715594.html"
  },
  {
    "title": "Amgen profits rise, next MariTide studies start by mid-year",
    "link": "https://finance.yahoo.com/news/amgen-profit-beats-estimates-next-210611912.html"
  },
  {
    "title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS",
    "link": "https://finance.yahoo.com/news/amgen-reports-fourth-quarter-full-210100757.html"
  },
  {
    "title": "These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025",
    "link": "https://finance.yahoo.com/news/were-5-top-performing-stocks-191039006.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-092300966.html"
  }
]